{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:47:50Z","timestamp":1795042070573,"version":"4.10.2"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To provide an update on state-of-the-art evidence on the role of immunometabolism reprogramming in the pathogenesis of systemic lupus erythematosus (SLE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Mitochondrial dysfunction and enhanced oxidative stress, along with specific defects in other metabolic pathways, can promote dysregulation of innate and adaptive immune responses in SLE. These abnormalities appear to be driven by genetic and epigenetic factors, modulated by stochastic events. In addition to extensive descriptions of abnormalities in immunometabolism of lupus lymphocytes, recent studies support the critical role of dysregulation of metabolic pathways in innate immune cells including neutrophils, macrophages and dendritic cells, in SLE pathogenesis. Recent abnormalities described in lipid metabolism have been associated with SLE disease activity and related damage. Promising therapeutic strategies that target these metabolic abnormalities have recently been described in SLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Fundamental new insights regarding the role of mitochondrial dysfunction in innate immune dysregulation in SLE pathogenesis have recently emerged. Defects in specific molecular pathways pertinent to immunometabolism in SLE have been described. New insights in translational medicine and promising therapeutic targets have been proposed based on these recent findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000738","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T09:00:16Z","timestamp":1598000416000},"page":"562-571","source":"Crossref","is-referenced-by-count":35,"title":["Immunometabolism in the pathogenesis of systemic lupus erythematosus: an update"],"prefix":"10.1097","volume":"32","author":[{"given":"Jorge","family":"Romo-Tena","sequence":"first","affiliation":[{"name":"Systemic Autoimmunity Branch, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Medical Science PhD Program, School of Medicine, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana J.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Systemic Autoimmunity Branch, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/imr.12847","article-title":"Metabolic determinants of lupus pathogenesis","volume":"295","author":"Teng","year":"2020","journal-title":"Immunol Rev"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/imt-2019-0002","article-title":"Immunometabolism: an overview and therapeutic prospects in autoimmune diseases","volume":"11","author":"Stathopoulou","year":"2019","journal-title":"Immunotherapy"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2017.43","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"13","author":"Morel","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"R4-20230829","first-page":"1120","article-title":"Immunometabolism and systemic lupus erythematosus","volume":"50","author":"Xiao","year":"2018","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"R5-20230829","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20200012","article-title":"Metabolic targets for treatment of autoimmune diseases","volume":"2","author":"Piranavan","year":"2020","journal-title":"Immunometabolism"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2174\/0929867326666181126165139","article-title":"The role of mitochondria in systemic lupus erythematosus: a glimpse of various pathogenetic mechanisms","volume":"27","author":"Yang","year":"2018","journal-title":"Curr Med Chem"},{"key":"R7-20230829","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20200009","article-title":"T cell metabolism in lupus","volume":"2","author":"Vukelic","year":"2020","journal-title":"Immunometabolism"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.aav4011","article-title":"VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease","volume":"366","author":"Kim","year":"2019","journal-title":"Science"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.semarthrit.2019.04.006","article-title":"Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus","volume":"48","author":"Takeshima","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1038\/s41598-019-40900-3","article-title":"Antimitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations","volume":"9","author":"Becker","year":"2019","journal-title":"Sci Rep"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"108349","DOI":"10.1016\/j.clim.2020.108349","article-title":"The binding of SLE autoantibodies to mitochondria","volume":"212","author":"Pisetsky","year":"2020","journal-title":"Clin Immunol"},{"key":"R13-20230829","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000387","article-title":"Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice","volume":"7","author":"Fortner","year":"2020","journal-title":"Lupus Sci Med"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4049\/jimmunol.1801651","article-title":"Metformin inhibits the type 1 IFN response in human CD4(+) T cells","volume":"203","author":"Titov","year":"2019","journal-title":"J Immunol"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1172\/JCI127949","article-title":"Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity","volume":"129","author":"Katsuyama","year":"2019","journal-title":"J Clin Invest"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/rheumatology\/keaa094","article-title":"Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus","volume":"59","author":"Katsuyama","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1007\/s11033-020-05446-y","article-title":"Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk","volume":"47","author":"Saravani","year":"2020","journal-title":"Mol Biol Rep"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"e12810","DOI":"10.1111\/sji.12810","article-title":"MiR-183 delivery attenuates murine lupus nephritis-related injuries via targeting mTOR","volume":"90","author":"Li","year":"2019","journal-title":"Scand J Immunol"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0961203319829853","article-title":"Downregulation of miR-633 activated AKT\/mTOR pathway by targeting AKT1 in lupus CD4(+) T cells","volume":"28","author":"Chen","year":"2019","journal-title":"Lupus"},{"key":"R20-20230829","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134010","article-title":"Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1\/RAB4 expression and mTOR activation","volume":"5","author":"Godavarthy","year":"2020","journal-title":"JCI Insight"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41419-020-2362-y","article-title":"B cells control lupus autoimmunity by inhibiting Th17 and promoting Th22 cells","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2019.09.022","article-title":"Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway","volume":"50","author":"He","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R23-20230829","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20200013","article-title":"Increased expression of EZH2 is mediated by higher glycolysis and mTORC1 activation in lupus CD4(+) T Cells","volume":"2","author":"Zheng","year":"2020","journal-title":"Immunometabolism"},{"key":"R24-20230829","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa060","article-title":"Inhibition of mTOR suppresses IFNalpha production and the STING pathway in monocytes from systemic lupus erythematosus patients","author":"Murayama","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbadis.2018.10.007","article-title":"mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b(+)Gr1(+) cells","volume":"1865","author":"Shi","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fcell.2019.00028","article-title":"Induces MCJ expression that links T cell proliferation with caspase-3 activity and death","volume":"7","author":"Secinaro","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.41019","article-title":"Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in MRL\/lpr mice and experimental autoimmune encephalomyelitis","volume":"71","author":"Kono","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"e1483","DOI":"10.1002\/wsbm.1483","article-title":"Glucose transporter 1 in rheumatoid arthritis and autoimmunity","volume":"12","author":"Zezina","year":"2020","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"R29-20230829","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127395","article-title":"Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation","volume":"4","author":"Kono","year":"2019","journal-title":"JCI Insight"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/art.40785","article-title":"Promotion of calcium\/calmodulin-dependent protein kinase 4 by GLUT1-dependent glycolysis in systemic lupus erythematosus","volume":"71","author":"Koga","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.1073\/pnas.1805717115","article-title":"Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation","volume":"115","author":"Kono","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.4049\/jimmunol.1800002","article-title":"Myeloid Slc2a1-deficient murine model revealed macrophage activation and metabolic phenotype are fueled by GLUT1","volume":"202","author":"Freemerman","year":"2019","journal-title":"J Immunol"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jpba.2019.06.005","article-title":"Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus","volume":"174","author":"Ferreira","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/art.41059","article-title":"High-density lipoprotein in lupus: disease biomarkers and potential therapeutic strategy","volume":"72","author":"Kim","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"e000332","DOI":"10.1136\/lupus-2019-000332","article-title":"Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE","volume":"6","author":"Purmalek","year":"2019","journal-title":"Lupus Sci Med"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2019.05.004","article-title":"Elevated oxidized lipids, antilipid autoantibodies and oxidized lipid immune complexes in active SLE","volume":"205","author":"Ye","year":"2019","journal-title":"Clin Immunol"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"e0230499","DOI":"10.1371\/journal.pone.0230499","article-title":"Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL\/lpr lupus mice","volume":"15","author":"Nowling","year":"2020","journal-title":"PLoS One"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41467-019-13603-6","article-title":"B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids","volume":"11","author":"Sanchez","year":"2020","journal-title":"Nat Commun"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3389\/fimmu.2019.02851","article-title":"Docosahexaenoic acid consumption impedes early interferon- and chemokine-related gene expression while suppressing silica-triggered flaring of murine lupus","volume":"10","author":"Benninghoff","year":"2019","journal-title":"Front Immunol"},{"key":"R40-20230829","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99276","article-title":"Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus","volume":"3","author":"Carlucci","year":"2018","journal-title":"JCI Insight"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"25222","DOI":"10.1073\/pnas.1908576116","article-title":"Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus","volume":"116","author":"Mistry","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/art.38703","article-title":"Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/art.41128","article-title":"Improved mitochondrial metabolism and reduced inflammation following attenuation of murine lupus with coenzyme Q10 analog idebenone","volume":"72","author":"Blanco","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"274ra18","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci Transl Med"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","article-title":"Metformin suppresses systemic autoimmunity in roquin (san\/san) mice through inhibiting B cell differentiation into plasma cells via regulation of AMPK\/mTOR\/STAT3","volume":"198","author":"Lee","year":"2017","journal-title":"J Immunol"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4049\/immunohorizons.2000033","article-title":"Efficacy of the combination of metformin and CTLA4Ig in the (NZB x NZW)F1 mouse model of lupus nephritis","volume":"4","author":"Cornaby","year":"2020","journal-title":"Immunohorizons"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1136\/annrheumdis-2013-203794","article-title":"HRES-1\/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE","volume":"73","author":"Caza","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0961203318819131","article-title":"Allogeneic adipose-derived stem cells suppress mTORC1 pathway in a murine model of systemic lupus erythematosus","volume":"28","author":"Wei","year":"2019","journal-title":"Lupus"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41419-019-1315-9","article-title":"Baicalin ameliorates lupus autoimmunity by inhibiting differentiation of Tfh cells and inducing expansion of Tfr cells","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fphar.2019.00082","article-title":"Clinical experience of sirolimus regarding efficacy and safety in systemic lupus erythematosus","volume":"10","author":"Eriksson","year":"2019","journal-title":"Front Pharmacol"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1042\/CS20190536","article-title":"Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis","volume":"133","author":"Zhang","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12865-019-0305-0","article-title":"Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17\/Treg cells in refractory SLE patients","volume":"20","author":"Zhao","year":"2019","journal-title":"BMC Immunol"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3899\/jrheum.180507","article-title":"Longterm data on sirolimus treatment in patients with lupus nephritis","volume":"45","author":"Yap","year":"2018","journal-title":"J Rheumatol"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-Acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI73411","article-title":"CaMK4-dependent activation of AKT\/mTOR and CREM-alpha underlies autoimmunity-associated Th17 imbalance","volume":"124","author":"Koga","year":"2014","journal-title":"J Clin Invest"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3389\/fimmu.2019.00833","article-title":"Targeting T cell activation and lupus autoimmune phenotypes by inhibiting glucose transporters","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"R57-20230829","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040323","article-title":"The potential use of metformin, dipyridamole, N-acetylcysteine and statins as adjunctive therapy for systemic lupus erythematosus","volume":"8","author":"Tan","year":"2019","journal-title":"Cells"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/annrheumdis-2013-204351","article-title":"Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment","volume":"74","author":"Ruiz-Limon","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T03:14:44Z","timestamp":1693278884000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000738","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]}}}